Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD) of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with SARS-CoV-2 (of which 93% required hospitalization) up to 122 days after symptom onset and compared them to responses in 1548 ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Anita S., Jones, Forrest K., Nodoushani, Ariana, Kelly, Meagan, Becker, Margaret, Slater, Damien, Mills, Rachel, Teng, Erica, Kamruzzaman, Mohammad, Garcia-Beltran, Wilfredo F., Astudillo, Michael, Yang, Diane, Miller, Tyler E., Oliver, Elizabeth, Fischinger, Stephanie, Atyeo, Caroline, Iafrate, A. John, Calderwood, Stephen B., Lauer, Stephen A., Yu, Jingyou, Li, Zhenfeng, Feldman, Jared, Hauser, Blake M., Caradonna, Timothy M., Branda, John A., Turbett, Sarah E., LaRocque, Regina C., Mellon, Guillaume, Barouch, Dan H., Schmidt, Aaron G., Azman, Andrew S., Alter, Galit, Ryan, Edward T, Harris, Jason B., Charles, Richelle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857394/
https://www.ncbi.nlm.nih.gov/pubmed/33033172
http://dx.doi.org/10.1126/sciimmunol.abe0367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857394/
https://www.ncbi.nlm.nih.gov/pubmed/33033172
http://dx.doi.org/10.1126/sciimmunol.abe0367

Ejemplares similares